| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | -0.034 | 0.8 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.8 |